118 related articles for article (PubMed ID: 6972550)
21. HLA-related lymphocyte responsiveness in psoriasis.
Gross WL; Vorwerk I; Westphal E; Christophers E; Hahn G; Schlaak M
Int Arch Allergy Appl Immunol; 1983; 70(2):151-6. PubMed ID: 6822440
[TBL] [Abstract][Full Text] [Related]
22. [Delayed hypersensitivity in patients with craniocerebral injuries].
Detlav IE; Drake RB; Skushka MA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(3):326-9. PubMed ID: 7395407
[TBL] [Abstract][Full Text] [Related]
23. [Drug-induced lymphocyte stimulation test].
Aida H
Nihon Rinsho; 2010 Jun; 68 Suppl 6():46-8. PubMed ID: 20941998
[No Abstract] [Full Text] [Related]
24. In vitro effects of solubilized HLA-DR--role in immunoregulation?
Claus R; Hausmann S; Zavazava N; Walzel H; Schulze HA; Köhler H; Friemel H; Müller-Ruchholtz W
Cell Immunol; 1994 May; 155(2):476-85. PubMed ID: 8181077
[TBL] [Abstract][Full Text] [Related]
25. [Cellular immunity in psoriasis].
Heid E; Bigel P; Reuter G; Fourssereau J; Basset A
Ann Dermatol Syphiligr (Paris); 1976; 103(5-6):577-9. PubMed ID: 1087848
[No Abstract] [Full Text] [Related]
26. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
Zollner TM; Podda M; Pien C; Elliott PJ; Kaufmann R; Boehncke WH
J Clin Invest; 2002 Mar; 109(5):671-9. PubMed ID: 11877475
[TBL] [Abstract][Full Text] [Related]
27. In vitro tests in drug hypersensitivity diagnosis.
Lochmatter P; Zawodniak A; Pichler WJ
Immunol Allergy Clin North Am; 2009 Aug; 29(3):537-54. PubMed ID: 19563996
[TBL] [Abstract][Full Text] [Related]
28. Depletion of protein kinase C induced by an anti HLA class I monoclonal antibody in phytohemagglutinin activated human T cells.
Poltronieri L; Melloni E; Rubini M; Selvatici R; Mazzilli C; Baricordi R; Gandini E
Biochem Biophys Res Commun; 1988 May; 152(3):951-6. PubMed ID: 3259877
[TBL] [Abstract][Full Text] [Related]
29. [The blast transformation test and the Multitest CMI in evaluating nonspecific immunologic reactivity in patients with cancer of the larynx].
Zawisza E; Tarchalska B; Samoliński B; Swierczyński Z
Pol Tyg Lek; 1987 Jul 6-7; 42(27-28):830-2. PubMed ID: 3684759
[No Abstract] [Full Text] [Related]
30. T-lymphocyte chemotaxis to IL-8 in patients with psoriasis in vitro.
Zheng M; Sun G; Cai S; Mrowietz U
Chin Med J (Engl); 1998 Feb; 111(2):166-8. PubMed ID: 10374381
[TBL] [Abstract][Full Text] [Related]
31. [Changes in the detectability of HLA antigens on lymphocyte subpopulations induced by mitogens and corticosteroids].
Volgin AIu; Pevnitskiĭ LA
Biull Eksp Biol Med; 1982 Jan; 93(1):45-7. PubMed ID: 6978158
[TBL] [Abstract][Full Text] [Related]
32. [Peripheral blood lymphocyte transformation test in various skin diseases of allergic origin].
Panasiuk J
Przegl Dermatol; 1980; 67(6):823-9. PubMed ID: 6972552
[No Abstract] [Full Text] [Related]
33. Psoriasis as a T cell-mediated autoimmune disease.
Barker JN
Hosp Med; 1998 Jul; 59(7):530-3. PubMed ID: 9798540
[TBL] [Abstract][Full Text] [Related]
34. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions.
Beeler A; Engler O; Gerber BO; Pichler WJ
J Allergy Clin Immunol; 2006 Feb; 117(2):455-62. PubMed ID: 16461148
[TBL] [Abstract][Full Text] [Related]
35. Immunopathogenesis of psoriasis.
Lee MR; Cooper AJ
Australas J Dermatol; 2006 Aug; 47(3):151-9. PubMed ID: 16866993
[TBL] [Abstract][Full Text] [Related]
36. HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis.
Shen Z; Wang G; Fan JY; Li W; Liu YF
J Dermatol Sci; 2005 Apr; 38(1):25-39. PubMed ID: 15795121
[TBL] [Abstract][Full Text] [Related]
37. [The immunological mechanisms of the tissue lesions in endogenous uveitis].
Todea V
Oftalmologia; 1994; 38(3):201-4. PubMed ID: 8060956
[TBL] [Abstract][Full Text] [Related]
38. [Immunological response of the delayed type in acute cerebrovascular disorders].
Paprocka K
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():189-99. PubMed ID: 6443816
[No Abstract] [Full Text] [Related]
39. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.
Zeltser R; Valle L; Tanck C; Holyst MM; Ritchlin C; Gaspari AA
Arch Dermatol; 2001 Jul; 137(7):893-9. PubMed ID: 11453808
[TBL] [Abstract][Full Text] [Related]
40. Immunological alterations in psoriasis.
Wahba A
Int J Dermatol; 1980 Apr; 19(3):124-9. PubMed ID: 6248472
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
